E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPACEI0420(ACE-inhibitory peptide)
DFBP ID DFBPACEI0420
Peptide sequence LHLPLP
Type Native peptide
Peptide/Function name ACE-inhibitory peptide
Function-activity relationship
Main bioactivity ACE-inhibitory activity
Otheir bioactivity Antihypertensive activity [D1], Multifunctional activity [D2]
Calculated physicochemical properties
Three-letter amino acid Leu-His-Leu-Pro-Leu-Pro
Single-letter amino acid LHLPLP
Peptide length 6
Peptide mass
Experimental mass Theoretical mass
688.4 Da 688.85 Da c
Net charge 0.00 c
Isoelectric point (pI) 7.79 c
IC50 5.5 ± 0.4 uM
pIC50 -0.74
GRAVY 0.8333 c
Hydrophilic residue ratio 83.33% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal
Organism/Source Bovine milk protein
Precursor protein β-Casein
Residue position

f(133-138)

Precursor protein(s) search
Link-research
Link 1: DFBPACEI1478----Human milk protein----β-Casein
Biological/Functional activity & target protein
ACE-inhibitory activity

The peptide exhibited strong Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) inhibitory activity with an IC50 value of 5.5 ± 0.4 uM, and its ACE inhibitory pattern was shown by Lineweaver–Burk plots to be a competitive inhibition pattern. 


Specific target protein(s) Specific Target Protein(s):
Angiotensin-converting enzyme
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools Bitter taste prediction
SMILES N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)O
Preparation method
Mode of preparation

Fermentation

Enzyme(s)/starter culture

Milk was fermented with Enterococcus faecalis, CECT 5727.

Stability & Cytotoxicity
Peptide stability
Literature report: N.D
EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: N.D
Prediction: ToxinPred
Additional information
Additional information

The potential of the peptide for use in functional foods to mitigate hypertension would seem to merit further clinical studies in humans.

Database cross-references
DFBP
[D1] DFBPANHY0002
[D2] DFBPMUFU0117
BIOPEP-UWM [D3] 2667
APD [D4] -
BioPepDB [D5] -
MBPDB [D6] -
Reference(s)
Primary literature Quirós, A., Ramos, M., Muguerza, B., Delgado, M.A., Miguel, M., Aleixandre, A., et al. Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis. International Dairy Journal. 2007, 17, 33-41.
Other literature(s)

[1] Kohmura M, Nio N, Kubo K, et al. Inhibition of angiotensin-converting enzyme by synthetic peptides of human. BETA.-casein[J]. Journal of the Agricultural Chemical Society of Japan, 1989, 53(8):2107-2114.
[2] Hernandezledesma B, Quiros A, Amigo L, et al. Identification of bioactive peptides after digestion of human milk and infant formula with pepsin and pancreatin[J]. International Dairy Journal, 2007, 17(1):42-49.
[3] Quiros A, Ramos M, Muguerza B, et al. Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis[J]. International Dairy Journal, 2007, 17(1):33-41.

PubDate 2007
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214